The concentration in urine of N-acetyl-hydroxy-propyl-cisteine (3HPMA), acrolein metabolite, can be used as a marker of the illness risk of smokers and the relative concentration to creatinine employed to verify the effect of moving from burned tobacco practice to nicotine vaping.